The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
作者信息
Brent David A
机构信息
Western Psychiatric Institute, 3811 Ohara St., Pittsburgh, PA 15213, USA.
出版信息
Depress Anxiety. 2009;26(10):871-4. doi: 10.1002/da.20617.
Abstract
摘要
相似文献
1
The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
Depress Anxiety. 2009;26(10):871-4. doi: 10.1002/da.20617.
2
Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
Am J Psychiatry. 2009 Apr;166(4):418-26. doi: 10.1176/appi.ajp.2008.08070976. Epub 2009 Feb 17.
3
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.
JAMA. 2008 Feb 27;299(8):901-913. doi: 10.1001/jama.299.8.901.
4
[Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
Encephale. 2005 May-Jun;31(3):309-16. doi: 10.1016/s0013-7006(05)82395-4.
5
Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
J Child Adolesc Psychopharmacol. 2019 May;29(4):250-255. doi: 10.1089/cap.2018.0145. Epub 2019 Feb 27.
6
A depressed adolescent at high risk of suicidal behavior.
Am J Psychiatry. 2008 Mar;165(3):323-8; quiz 408. doi: 10.1176/appi.ajp.2007.07101549.
7
TORDIA: unique opportunity to explore half-life theory.
Am J Psychiatry. 2009 Aug;166(8):936; author reply 936-7. doi: 10.1176/appi.ajp.2009.09050601.
8
Teenaged, depressed, and treatment resistant: what predicts self-harm?
Am J Psychiatry. 2009 Apr;166(4):385-7. doi: 10.1176/appi.ajp.2009.09020265.
9
Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
J Am Acad Child Adolesc Psychiatry. 2009 Mar;48(3):330-339. doi: 10.1097/chi.0b013e3181977476.
10
Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Can J Psychiatry. 2005 Nov;50(13):877; author reply 877-8. doi: 10.1177/070674370505001320.
引用本文的文献
1
Treatment Refractory Internalizing Behaviour Across Disorders: An Aetiological Model for Severe Emotion Dysregulation in Adolescence.
Child Psychiatry Hum Dev. 2021 Jun;52(3):515-532. doi: 10.1007/s10578-020-01036-y. Epub 2020 Aug 3.
2
A Randomized Controlled Trial: Attachment-Based Family and Nondirective Supportive Treatments for Youth Who Are Suicidal.
J Am Acad Child Adolesc Psychiatry. 2019 Jul;58(7):721-731. doi: 10.1016/j.jaac.2018.10.006. Epub 2018 Oct 30.
3
Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescents.
Psychiatry Res Neuroimaging. 2016 Jan 30;247:25-33. doi: 10.1016/j.pscychresns.2015.11.005. Epub 2015 Nov 27.
4
Exposure to early adversity: Points of cross-species translation that can lead to improved understanding of depression.
Dev Psychopathol. 2015 May;27(2):477-91. doi: 10.1017/S0954579415000103.
5
Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
Cochrane Database Syst Rev. 2014 Nov 30;2014(11):CD008324. doi: 10.1002/14651858.CD008324.pub3.
6
The use of cognitive behavioral therapy in the treatment of resistant depression in adolescents.
Adolesc Health Med Ther. 2012 Sep 10;3:95-104. doi: 10.2147/AHMT.S13781. eCollection 2012.
7
The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.
Am J Psychiatry. 2011 Dec;168(12):1266-77. doi: 10.1176/appi.ajp.2011.10111704.
8
Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.
Child Adolesc Psychiatry Ment Health. 2010 Jan 5;4:1. doi: 10.1186/1753-2000-4-1.
本文引用的文献
1
STAR*D: revising conventional wisdom.
CNS Drugs. 2009 Aug;23(8):627-47. doi: 10.2165/00023210-200923080-00001.
2
Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
Am J Psychiatry. 2009 Apr;166(4):418-26. doi: 10.1176/appi.ajp.2008.08070976. Epub 2009 Feb 17.
3
Pediatric depression: is there evidence to improve evidence-based treatments?
J Child Psychol Psychiatry. 2009 Jan;50(1-2):143-52. doi: 10.1111/j.1469-7610.2008.02037.x.
4
Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
J Am Acad Child Adolesc Psychiatry. 2009 Mar;48(3):330-339. doi: 10.1097/chi.0b013e3181977476.
5
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.
JAMA. 2008 Feb 27;299(8):901-913. doi: 10.1001/jama.299.8.901.
6
Pupillary reactivity to emotional information in child and adolescent depression: links to clinical and ecological measures.
Am J Psychiatry. 2007 Dec;164(12):1873-80. doi: 10.1176/appi.ajp.2007.06111816.
7
Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial.
BMJ. 2007 Jul 21;335(7611):142. doi: 10.1136/bmj.39224.494340.55. Epub 2007 Jun 7.
8
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
JAMA. 2007 Apr 18;297(15):1683-96. doi: 10.1001/jama.297.15.1683.
9
Treatment for Adolescents with Depression Study (TADS): safety results.
J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1440-55. doi: 10.1097/01.chi.0000240840.63737.1d.
10
Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).
J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1427-39. doi: 10.1097/01.chi.0000240838.78984.e2.
Zotero 插件